Rees Matthew G, Raimondo Anne, Wang Jian, Ban Matthew R, Davis Mindy I, Barrett Amy, Ranft Jessica, Jagdhuhn David, Waterstradt Rica, Baltrusch Simone, Simeonov Anton, Collins Francis S, Hegele Robert A, Gloyn Anna L
Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford OX3 7LE, UK, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford OX3 7LE, UK.
Hum Mol Genet. 2014 Oct 15;23(20):5570-8. doi: 10.1093/hmg/ddu269. Epub 2014 May 30.
Significant resources have been invested in sequencing studies to investigate the role of rare variants in complex disease etiology. However, the diagnostic interpretation of individual rare variants remains a major challenge, and may require accurate variant functional classification and the collection of large numbers of variant carriers. Utilizing sequence data from 458 individuals with hypertriglyceridemia and 333 controls with normal plasma triglyceride levels, we investigated these issues using GCKR, encoding glucokinase regulatory protein. Eighteen rare non-synonymous GCKR variants identified in these 791 individuals were comprehensively characterized by a range of biochemical and cell biological assays, including a novel high-throughput-screening-based approach capable of measuring all variant proteins simultaneously. Functionally deleterious variants were collectively associated with hypertriglyceridemia, but a range of in silico prediction algorithms showed little consistency between algorithms and poor agreement with functional data. We extended our study by obtaining sequence data on family members; however, functional variants did not co-segregate with triglyceride levels. Therefore, despite evidence for their collective functional and clinical relevance, our results emphasize the low predictive value of rare GCKR variants in individuals and the complex heritability of lipid traits.
为了研究罕见变异在复杂疾病病因学中的作用,人们在测序研究中投入了大量资源。然而,对单个罕见变异进行诊断性解读仍然是一项重大挑战,可能需要对变异进行准确的功能分类,并收集大量的变异携带者。利用458名高甘油三酯血症患者和333名血浆甘油三酯水平正常的对照者的序列数据,我们以编码葡萄糖激酶调节蛋白的GCKR为研究对象,探讨了这些问题。通过一系列生化和细胞生物学检测,包括一种能够同时检测所有变异蛋白的新型高通量筛选方法,对在这791名个体中鉴定出的18种罕见非同义GCKR变异进行了全面表征。功能有害的变异与高甘油三酯血症总体相关,但一系列的计算机预测算法在算法之间几乎没有一致性,与功能数据的一致性也很差。我们通过获取家庭成员的序列数据扩展了研究;然而,功能变异与甘油三酯水平并未共分离。因此,尽管有证据表明它们具有总体功能和临床相关性,但我们的结果强调了罕见GCKR变异在个体中的低预测价值以及脂质性状复杂的遗传特性。